Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Antiarrhythmic effects of 5-HT2 antagonist/TxA2 antagonist combination investigated

Aug. 28, 1997

No Comments

Parke-Davis initiates QUASAR trial of quinapril

Aug. 28, 1997

No Comments

Cardiovascular and antiarrhythmic activities of HNS-32

Aug. 27, 1997

No Comments

Innothera describes agents for venous function deficiency

Aug. 27, 1997

No Comments

TNF-alpha inhibitors for septic shock and other inflammatory diseases

Aug. 26, 1997

No Comments

Medtronic initiates U.S. clinical trials of beStent Rival

Aug. 25, 1997

No Comments

Xoma discloses rBPI-Ig fusion proteins

Aug. 25, 1997

No Comments

PDGFr tyrosine kinase inhibitor with potential in atherosclerosis

Aug. 25, 1997

No Comments

Merck KGaA begins development of cardioprotectant

Aug. 20, 1997

No Comments

Viazem approved in 10 European countries

Aug. 20, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Cardiovascular
RSS

Antiarrhythmic effects of 5-HT2 antagonist/TxA2 antagonist combination investigated

Parke-Davis initiates QUASAR trial of quinapril

Cardiovascular and antiarrhythmic activities of HNS-32

Innothera describes agents for venous function deficiency

TNF-alpha inhibitors for septic shock and other inflammatory diseases

Medtronic initiates U.S. clinical trials of beStent Rival

Xoma discloses rBPI-Ig fusion proteins

PDGFr tyrosine kinase inhibitor with potential in atherosclerosis

Merck KGaA begins development of cardioprotectant

Viazem approved in 10 European countries

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Cardiovascular RSS

Cardiovascular
RSS